| 查看: 1970 | 回复: 57 | |||
| 【有奖交流】积极回复本帖子，参与交流，就有机会分得作者 chu_mouse 的 3 个金币 ，回帖就立即获得 1 个金币，每人有 1 次机会 | |||
[交流]
清华药学院储凌课题组招聘有机化学、化学生物学、生物方向博后及研究助理
|
|||
|
About the PI Ling Chu was born and raised in Hefei, Anhui, China. He received a B.S. degree in Chemistry from the University of Science and Technology of China in 2012. He completed his Ph.D. study at the Scripps Research Institute, where he conducted research with Prof. Jin-Quan Yu on the development of Palladium-catalyzed C-H activation reactions. After completing his Ph.D. in 2017, he switched his research field to chemical biology and worked with Prof. Alanna Schepartz and Prof. Derek Toomre as a Brown-Coxe postdoctoral fellow at Yale School of Medicine. In the Schepartz/Toomre lab, he developed new chemical biology tools for two-color long-time lapse live-cell super-resolution imaging. He then joined Prof. Craig Crews’ lab in 2019 as a postdoctoral associate, where he led the development of first PROTAC capable of degrading oncogenic KRASG12C. Ling will join School of Pharmaceutical Sciences, Tsinghua University as an assistant professor in 2021. His research interest lies at the interface of chemistry and biology. Website: chu-lab.org Email: chu_lab@126.com About the research New chemical biology tools to explore the beyond-rule-of-5 drug space There is an increasing need to pursuit less druggable targets that offer high potential for the development of new therapeutic agents and may require beyond-rule-of-5 (bRo5) molecules in order to take advantage of these opportunities. Nevertheless, bRo5 chemical space remains relatively unexplored, most likely due to the perceived non-oral properties, increased complexity of compounds in this space and the synthetic chemistry challenges associated with its navigation. There is a pressing need to develop new technologies for the discovery and oral delivery of bRo5 drugs. We will develop new chemical biology approaches that enable phenotypic screening of large, de novo bRo5 compound libraries inside living cells. Such efforts could potentially yield novel hits for “undruggable” targets. The strategies used here will be further pursued for applications in oral delivery of bRo5 compounds. Affecting protein stability as a new strategy to target KRAS The Kirsten rat sarcoma viral oncogene homologue (KRAS) gene is one of the most frequently mutated oncogenes in cancer. KRAS is mutated in ～30% of human cancers and is one of the most sought-after targets for pharmacological modulation. Despite its well-recognized importance in cancer malignancy, continuous efforts in the past three decades failed to develop approved therapies for KRAS mutant cancer. Recent efforts in direct targeting KRASG12C have resulted in small molecule inhibitors that showed great promise in early clinical trials. However, G12C mutant only represents a small percentage of patients with oncogenic KRAS mutations. To explore a general strategy to target KRAS, we will combine chemical screen and genetic screen to identify small molecules and genes that can destabilize KRAS across different mutant KRAS cell lines. Results from these screens will provide novel therapeutic leads and mechanistic insights of KRAS degradation pathway. Leveraging these findings, we hope to develop next-gen small molecule therapeutics for the treatment of KRAS mutant cancer. New tools for live-cell protein labeling and super-resolution imaging Proteins are the essential components in cell function. To understand the function of proteins in living cells, it is important to know the properties of proteins in the temporal and spatial context of the cell. Currently, live-cell protein labeling and imaging technologies have several limitations: 1) Widely adopted tools for live-cell protein labeling have a large size (20-30kDa), giving rise to concerns that they may interfere with protein folding, trafficking, activity, and interactions; 2) Fluorescence proteins or small molecule dyes bleach quickly under super-resolution imaging conditions, thus prevent long-term protein imaging. To solve these problems, we will develop short peptide tags for site-specific protein labeling in live cells. Such tags contain only a few amino acids and will have minimal perturbation of protein function in live cells. We will also develop bleaching-resistant live cell protein imaging tools that allow biologists to visualize the dynamics of proteins at the nanoscopy level (resolution<50 nm) with unlimited “photon budget”. Training We are an interdisciplinary research group working at the interface of chemistry and biology. Students in the lab will receive multidisciplinary training in experimental techniques ranging from synthetic chemistry to fluorescence microscopy to cellular studies. Representative skill sets in the group are given below. Chemical tools: organic synthesis, catalysts, medicinal chemistry, peptide synthesis Cell culture: mammalian cell lines, primary cell cultures Cell imaging: Confocal microscopy, STED, single-molecule microscopy, flow cytometry Molecular biology: Cloning, PCR, CRISPR Biochemistry: Protein purification, western blotting About the job We are actively recruiting. If you are passionate about chemical biology and drug discovery, come join us! Don’t hesitate to reach out to Dr. Chu at chu_lab@126.com Postdoc positions in biology Candidates should hold a PhD degree in cell biology, biochemistry, chemical biology, pharmacology or related fields. Experiences in phenotypic high-throughput assay or CRISPR screen are preferred but not required. If you are interested in joining the lab, please send your CV, research summary, and contact information of three referees to Dr. Chu at chu_lab@126.com. Postdoc positions in chemistry Candidates should hold a PhD degree in organic chemistry, medicinal chemistry or related fields. Experiences in transition-metal catalysts are preferred but not required. If you are interested in joining the lab, please send your CV, research summary, and contact information of three referees to Dr. Chu at chu_lab@126.com. Research assistants/Technicians Candidates should hold an MS or BS degree in chemistry or biology. If you are interested in joining the lab, please send your CV and contact information of three referees to Dr. Chu at chu_lab@126.com. Competitive salaries will be provided for qualified applicants. [ Last edited by chu_mouse on 2020-11-1 at 02:29 ] |
回复此楼» 猜你喜欢
调剂
已经有3人回复
-
一志愿天津大学材料与化工275求调剂
已经有17人回复
-
材料工程专硕，一志愿中国矿业大学，总分314，求调剂
已经有3人回复
-
2026考研求调剂-材料类-本科211一志愿985-初试301分
已经有10人回复
-
一志愿中科大材料与化工。353分能调剂到哪？
已经有6人回复
-
085602化工求调剂
已经有7人回复
-
化工0817调剂
已经有5人回复
-
考研材料与化工，求调剂
已经有6人回复
-
读博申请
已经有6人回复
-
0856材料与化工353分求调剂
已经有10人回复
» 抢金币啦！回帖就可以得到:
-
南京工业大学杨建教授联合苏州实验室/上硅所联合培养博生研究生
+1/181
-
男征女，上海找一个真诚结婚的女朋友
+1/173
-
招果树学学博
+5/170
-
哈尔滨理工大学机械学院陈涛教授课题组面向秀学生招收2026级博士研究生
+1/86
-
Journal of Environmental Management投稿
+1/83
-
江西南部某一本高校招收环境、生物、计算机、农业等专业调剂生
+1/81
-
深圳理工大学梁国进课题组（成会明院士团队）诚聘科研助理教授、博士后
+1/32
-
厦门大学航空航天学院智能制造课题组招2026年申请审核制博士生1名
+1/31
-
金一政教授课题组招聘器件工艺工程师启事
+1/15
-
西京学院土木水利 2026 级研究生招生相关说明
+1/11
-
【神经生物学考博求助】
+1/10
-
鲁东大学水产养殖0908 有调剂名额，需要调剂联系
+1/9
-
内蒙古大学杰青团队张凡教授-杨阳课题组招收博士
+1/9
-
青岛科技大学高分子学院---生物大分子医学（BM3)团队---招收硕士生和博士生
+1/9
-
总分291英一、数二-中核论文（导师一作、本人二作）-一志愿211学硕-自我介绍详细
+1/4
-
大理大学博士招生
+1/4
-
[交流] 坐标北京 北京化工大学，诚聘机械类、材料类，化工类博后一位，青年教师一位
+1/4
-
湖南大学材料院陶益杰老师招收2026年秋季入学博士生一名-超材料方向
+1/3
-
总分291英一、数二-中核论文（导师一作、本人二作）-一志愿211学硕-自我介绍详细
+1/3
-
有青基找工作是优势还是劣势？
+1/3
15楼2020-10-30 08:02:10
18楼2020-10-31 11:45:21
42楼2020-11-15 11:00:56
简单回复
TTTiger2楼
2020-10-29 10:55
回复
chu_mouse(金币+1): 谢谢参与
好 发自小木虫IOS客户端
tzynew3楼
2020-10-29 11:12
回复
chu_mouse(金币+1): 谢谢参与
8 发自小木虫Android客户端
tzynew4楼
2020-10-29 11:12
回复
tzynew5楼
2020-10-29 11:12
回复
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
icanspll7楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
howtoge8楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
yaqianye9楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
shehuifei10楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
zzhello11楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
likecitywo12楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
encryption13楼
2020-10-29 12:49
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
ro1114楼
2020-10-29 12:50
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
DDDawn16楼
2020-10-30 13:55
回复
chu_mouse(金币+1): 谢谢参与
顶 发自小木虫IOS客户端
chu_mouse17楼
2020-10-31 10:54
回复
Haibo_19楼
2020-10-31 12:15
回复
chu_mouse(金币+1): 谢谢参与
。 发自小木虫Android客户端
DDDawn20楼
2020-10-31 12:27
回复
psylhh21楼
2020-10-31 17:56
回复
chu_mouse(金币+1): 谢谢参与
chuwanglinyx22楼
2020-11-01 17:30
回复
chu_mouse23楼
2020-11-01 23:55
回复
chuwanglinyx24楼
2020-11-02 16:13
回复
chu_mouse25楼
2020-11-03 08:45
回复
chu_mouse26楼
2020-11-04 00:03
回复
chusihai27楼
2020-11-04 07:41
回复
chu_mouse28楼
2020-11-05 08:53
回复
chuwanglinyx29楼
2020-11-05 15:29
回复
chusihai30楼
2020-11-06 05:40
回复
chuwanglinyx31楼
2020-11-06 19:06
回复
chuwanglinyx32楼
2020-11-08 08:25
回复
chuwanglinyx33楼
2020-11-10 14:40
回复
chu_mouse34楼
2020-11-11 12:25
回复
chusihai35楼
2020-11-12 11:39
回复
chuwanglinyx36楼
2020-11-13 08:56
回复
chusihai37楼
2020-11-13 12:51
回复
蓉蓉番薯38楼
2020-11-13 18:31
回复
zhx202012339楼
2020-11-13 20:46
回复
chusihai40楼
2020-11-14 12:08
回复
zhx202012341楼
2020-11-15 07:00
回复
chuwanglinyx43楼
2020-11-16 10:31
回复
chu_mouse44楼
2020-11-16 11:09
回复
chusihai45楼
2020-11-17 06:09
回复
chuwanglinyx46楼
2020-11-17 15:28
回复
chusihai47楼
2020-11-18 06:03
回复
chu_mouse48楼
2020-11-19 11:34
回复
chusihai49楼
2020-11-19 22:57
回复
zhx202012350楼
2020-11-21 10:10
回复
